Can Celltrion's Remicade biosim repeat its EU market-share steal in the U.S.?
Can Celltrion's Remicade biosim repeat its EU market-share steal in the U.S.? The first Remicade biosimilar has won approval in the U.S.–and now it's time to see if it'll cause […]